Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-27T11:17:29.769Z Has data issue: false hasContentIssue false

Chapter 11 - Management of women with prosthetic heart valves during pregnancy

from Section 4 - Antenatal Care: Specific Maternal Conditions

Published online by Cambridge University Press:  05 March 2016

By
Carole A. Warnes
Edited by
Philip J. Steer  and
Michael A. Gatzoulis
Philip J. Steer
Affiliation:
Chelsea and Westminster Hospital, London
Michael A. Gatzoulis
Affiliation:
Royal Brompton Hospital, London
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Heart Disease and Pregnancy , pp. 106 - 114
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Yun, KL, Miller, DC, Moore, KA, et al. Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. Ann Thorac Surg 1995;60(2 Suppl):S221–8.Google Scholar
Jamieson, WR, Janusz, MT, Miyagishima, RT, et al. The Carpentier–Edwards standard porcine bioprosthesis: Long-term evaluation of the high pressure glutaraldehyde fixed prosthesis. J Card Surg 1988;3(3 Suppl):321–36.Google ScholarPubMed
Badduke, BR, Jamieson, WR, Miyagishima, RT, et al. Pregnancy and childbearing in a population with biologic valvular prostheses. J Thorac Cardiovasc Surg 1991;102:179–86.Google Scholar
Avila, WS, Rossi, EG, Grinberg, M, et al. Influence of pregnancy after bioprosthetic valve replacement in young women: A prospective five year study. J Heart Valve Dis 2002;11:864–9.Google ScholarPubMed
Jamieson, WR, Miller, DC, Akins, CW, et al. Pregnancy and bioprostheses: Influence on structural valve deterioration. Ann Thorac Surg 1995;60 (2 Suppl):S282–6; discussion S287.CrossRefGoogle ScholarPubMed
North, RA, Sadler, L, Stewart, AW, et al. Long term survival and valve related complications in young women with cardiac valve replacements. Circulation 1999;99:2669–76.Google Scholar
McClintock, C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: No easy option. Thromb Res 2011;127 (Suppl 3):S56–60.Google Scholar
Elkayam, U, Singh, H, Irani, A, et al. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004;9:107–15.Google Scholar
Dahlman, TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993;168:1265–70.Google Scholar
Decousus, HA, Croze, M, Levi, FA, et al. Circadian changes in anticoagulant effect of heparin infused at a constant rate. Br Med J (Clin Res Ed) 1985;290:341–4.CrossRefGoogle Scholar
Chunilal, SD, Young, E, Johnston, MA, et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost 2002;87:92–7.Google ScholarPubMed
Brill-Edwards, PA, Demers, C, Donovan, D, et al. Establishing a therapeutic range for heparin therapy. Chest 1993;104:1679–84.Google Scholar
Nishimura, RA, Otto, CM, Bonow, RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438–88.Google Scholar
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar
Chan, WS, Anand, S, Ginsberg, JS. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med 2000;160:191–6.Google Scholar
Meschengieser, SS, Fondevila, CG, Santarelli, MT, et al. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999;82:23–6.Google Scholar
Hall, JG, Pauli, RM, Wilson, KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122–40.Google Scholar
Ginsberg, JS, Hirsh, J, Turner, DC, et al. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989;61:197–203.Google Scholar
Hung, L, Rahimtoola, SH. Prosthetic valves and pregnancy. Circulation 2003;107:1420–6.CrossRefGoogle ScholarPubMed
Cotrufo, M, de Luca, TS, Calabro, R, et al. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses. Eur J Cardiothorac Surg 1991;5:300–4; discussion 305.Google Scholar
Vitale, N, De Feo, M, De Santo, LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637–41.CrossRefGoogle ScholarPubMed
Mazibuko, B, Ramnarain, H, Moodley, J. An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa: A five-year experience. Cardiovasc J Afr 2012;23:216–21.Google Scholar
Sillesen, M, Hjortdal, V, Vejlstrup, N, et al. Pregnancy with prosthetic heart valves—30 years’ nationwide experience in Denmark. Eur J Cardiothorac Surg 2011;40:448–54.Google Scholar
Wesseling, J, Van Driel, D, Heymans, HS, et al. Coumarins during pregnancy: Long-term effects on growth and development of school-age children. Thromb Haemost 2001;85:609–13.Google Scholar
McClintock, C. Anticoagulant choices in pregnant women with mechanical heart valves: Balancing maternal and fetal risks—the difference the dose makes. Thromb Res 2013;131 (Suppl 1):S8–10.Google Scholar
Soma-Pillay, P, Nene, Z, Mathiva, TM, et al. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstset Medicine 2011;4:24–27.Google Scholar
Basude, S, Hein, C, Curtis, SL, et al. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: What are the risks? A retrospective observational study. BJOG 2012;119:1008–13; discussion 12–13.Google Scholar
Thorp, JA, Poskin, MF, McKenzie, DR, et al. Perinatal factors predicting severe intracranial hemorrhage. Am J Perinatol 1997;14:631–6.Google Scholar
White, RH, Ginsberg, JS. Low-molecular-weight heparins: Are they all the same? Br J Haematol 2003;121:12–20.Google Scholar
Rowan, JA, McCowan, LM, Raudkivi, PJ, et al. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001;185:633–7.Google Scholar
McClintock, C, McCowan, LM, North, RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG 2009;116:1585–92.Google Scholar
Abildgaard, U, Sandset, PM, Hammerstrom, J, et al. Management of pregnant women with mechanical heart valve prosthesis: Thromboprophylaxis with low molecular weight heparin. Thromb Res 2009;124:262–7.Google Scholar
Mahesh, B, Evans, S, Bryan, AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: Case report and a review of options for anticoagulation. J Heart Valve Dis 2002;11:745–50.Google Scholar
Yinon, Y, Siu, SC, Warshafsky, C, et al. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol 2009;104:1259–63.Google Scholar
Oran, B, Lee-Parritz, A, Ansell, J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004;92:747–51.Google Scholar
Saeed, CR, Frank, JB, Pravin, M, et al. A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves. Clin Appl Thromb Hemost 2011;17:313–19.Google Scholar
Quinn, J, Von Klemperer, K, Brooks, R, et al. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: A single-center experience. Haematologica 2009;94:1608–12.Google Scholar
Sephton, V, Farquharson, RG, Topping, J, et al. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol 2003;101:1307–11.Google Scholar
Casele, HL, Laifer, SA, Woelkers, DA, et al. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 1999;181(5 Pt 1):1113–17.Google Scholar
Barbour, LA, Oja, JL, Schultz, LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol 2004;191:1024–9.Google Scholar
Ginsberg, JS, Chan, WS, Bates, SM, et al. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003;163:694–8.CrossRefGoogle ScholarPubMed
Cappelleri, JC, Fiore, LD, Brophy, MT, et al. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A meta analysis. Am Heart J 1995;130 (3 Pt 1):547–52.Google Scholar
Imperiale, TF, Petrulis, AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991;266:260–4.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×